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Abstract
Background: Nestin is a protein belonging to class VI of intermediate filaments that is produced
in stem/progenitor cells in the mammalian CNS during development and is consecutively replaced
by other intermediate filament proteins (neurofilaments, GFAP). Down-regulated nestin may be re-
expressed in the adult organism under certain pathological conditions (brain injury, ischemia,
inflammation, neoplastic transformation). Our work focused on a detailed study of the nestin
cytoskeleton in cell lines derived from glioblastoma multiforme, because re-expression of nestin
together with down-regulation of GFAP has been previously reported in this type of brain tumor.
Methods: Two cell lines were derived from the tumor tissue of patients treated for glioblastoma
multiforme. Nestin and other cytoskeletal proteins were visualized using imunocytochemical
methods: indirect immunofluorescence and immunogold-labelling.
Results: Using epifluorescence and confocal microscopy, we described the morphology of nestin-
positive intermediate filaments in glioblastoma cells of both primary cultures and the derived cell
lines, as well as the reorganization of nestin during mitosis. Our most important result came
through transmission electron microscopy and provided clear evidence that nestin is present in the
cell nucleus.
Conclusion:  Detailed information concerning the pattern of the nestin cytoskeleton in
glioblastoma cell lines and especially the demonstration of nestin in the nucleus represent an
important background for further studies of nestin re-expression in relationship to tumor
malignancy and invasive potential.
Background
Nestin was originally described as an antigen of mono-
clonal antibody RAT401 against embryonic spinal cord
[1] and was subsequently identified as a class VI interme-
diate filament protein [2], which is closely related to the
neurofilament branch [3]. Nestin expression has been
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proved in both rodent and human neural stem cells in
various areas of the developing CNS as well as in immor-
talized stem cell and precursor cell lines [4-7]. During the
development of the mammalian CNS, expression of cyto-
plasmic intermediate filaments begins with cytokeratins
in early embryonic cells, through nestin and vimentin in
proliferating neuroepithelium to the neurofilaments and
GFAP in differentiated neurons and astrocytes, respec-
tively [3].
In the adult CNS, nestin is expressed only in stem cells of
the subventricular zone and to a lesser extent in the
choroid plexus [6]. In the normal adult human brain, sev-
eral morphological types of nestin-positive cells (neuron-
like, astrocyte-like, cells with smaller cell bodies and fewer
processes) are detectable in different areas of forebrain
[8]. Re-expression of down-regulated nestin was demon-
strated in reactive astrocytes following certain types of
brain injuries. This reversion to the immature phenotype
may serve to protect the cells, perhaps by making them
less susceptible to the attendant hypoxia that can occur
after injury [9]. Similarly, re-induction of nestin has been
reported in reactive astrocytes and endothelial cells in cer-
ebral abscesses, this process is probably caused by patho-
genic microorganisms inducing inflammatory stress in
the tissue [10].
Cell-specific expression of intermediate filament proteins
in normal tissue and the differences in this expression in
tumors represent an important tool for tumor diagnostics.
From this point of view, immunohistochemical and/or
immunocytochemical examination of nestin may serve as
a useful tool for classification and accurate grading of
human malignancies; especially since this protein has
been found in many kinds of tumors, predominantly in
tumors originating from immature, stem or progenitor
cells. Using immunohistochemical staining of paraffin-
embedded tissue sections, nestin expression has been
detected in brain tumors and tumors derived from CNS
tissues, such as, neurocytomas, gangliogliomas, ependy-
momas, pilocytic astrocytomas, malignant gliomas
including glioblastoma multiforme, primitive neuroecto-
dermal tumors (PNETs), medulloblastomas and medul-
loepitheliomas [4,11-16]. Up-regulation of nestin has
also been shown in rhabdomyosarcomas [17], gastroin-
testinal stromal tumors and interstitial cells of Cajal
[18,19], as well as in metastatic melanomas [20].
For detailed studies of intermediate filament protein
expression and regulation, several cell lines derived from
astrocytic tumors were used [21,22]. The high-grade astro-
cytomas, i.e. anaplastic astrocytoma (WHO grade III) and
glioblastoma multiforme (WHO grade IV), seem to be
exceptionally suitable models for the investigation of nes-
tin re-expression and its relationship to the other interme-
diate filament proteins. Significant changes in these
proteins (particularly GFAP and nestin), which are associ-
ated with motility and invasiveness, have been described
in the astrocytoma cell lines [21]. Other findings suggest
that the regulation of GFAP and nestin expression occurs
at the transcriptional level [22]. Even though there have
been several studies that focused on the detection of nes-
tin in both tumor and normal cells, there are few publica-
tions describing the morphology of nestin cytoskeleton in
individual human tumor cells. Therefore, the detailed pat-
tern of nestin-containing intermediate filaments as an
integral part of cytoskeletal structures is still unclear.
The aim of this study was to investigate, at both the cellu-
lar and ultrastructural levels, the nestin cytoskeleton in
individual cells of two cell lines derived from glioblast-
oma multiforme. We characterized the morphology of
nestin-positive filaments during the cell cycle, as well as
the intracellular distribution of nestin molecules in the
cytoplasm and also in the cell nucleus.
Methods
Cell culture
To obtain cell cultures, biopsy samples were taken from
patients surgically treated for glioblastoma multiforme.
The samples were coded and processed in the laboratory
in an anonymous manner. This project has been approved
by the Ethics Committee of the University Hospital Brno,
Czech Republic.
The specimens were briefly washed in 70% ethanol, fol-
lowed by two washing in PBS; the specimens were then
mechanically chopped into pieces about 2 mm in diame-
ter. After disaggregation, the pieces of tissue were washed
three more times in PBS, this time with centrifugation.
Next they were seeded into 25 cm2 cell culture flasks con-
taining 1 ml of complete medium, i.e. in DMEM (PAA
Laboratories, Linz, Austria) supplemented with 20% fetal
calf serum (PAA), 2 mM glutamine and antibiotics: 100
IU/ml of penicillin and 100 µg/ml of streptomycin (Bio-
Whittaker, Inc., Walkersville, MD, USA). The cells were
cultivated under standard conditions at 37°C and in an
atmosphere of 95% air : 5% CO2. Once the specimen
pieces had attached, the volume of the medium was grad-
ually increased to 5 ml over the next 48 hours. As soon as
the outgrowing cells covered about 60% of the surface,
they were trypsinized, diluted and transferred into a new
flask. A similar procedure was used for further subcultiva-
tions of both cell lines, which were derived from the pri-
mary cultures.
The expression of intermediate filament proteins and the
chromosomal abnormalities were analyzed at passages 3
through 5 for both cell lines; the detailed study of the nes-
tin cytoskeleton morphology using epifluorescenceBMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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microscopy was carried out between passages 6 and 9.
Confocal microscopy and ultrastructural analysis were
performed using the GM7 cell line at passages 15 through
22.
For the study of cytoskeletal structures, we used both epi-
fluorescence and transmission electron microscopy. Cell
suspensions with a concentration of 104 cells/ml were
inoculated onto glass coverslips and grown under stand-
ard conditions for 24 hours before cytoskeleton staining.
Visualization of cytoskeletal structures
The cells were rinsed in PBS and fixed using 3% para-for-
maldehyde (Sigma Chemical Co., St. Louis, MO, USA) in
PBS for 20 minutes at room temperature. After washing in
the same buffer, the cells were permeabilized with a 0.2%
solution of Triton X-100 detergent (Sigma) in PBS for 1
minute at room temperature. They were then washed with
PBS and incubated for 10 minutes with 2% BSA to block
the nonspecific binding of secondary antibodies.
Both cytoskeletal structures, i.e. intermediate filaments
and microtubules, were stained by indirect immunofluo-
rescence. To label the intermediate filaments, as our pri-
mary antibodies we used mouse monoclonal anti-
vimentin antibodies, clones VIM 13.2 and LN-6 (Sigma),
mouse monoclonal anti-vimentin antibody (Exbio,
Prague, Czech Republic), mouse monoclonal anti-GFAP
antibody, clone G-A-5 (Sigma), rabbit polyclonal anti-
GFAP antibody (Sigma), and mouse monoclonal human
specific anti-nestin antibody (Chemicon International
Inc., Temecula, CA, USA). Microtubules were labeled
using mouse monoclonal anti-α-tubulin antibody TU-01
(Exbio). All primary antibodies were applied at 37°C for
1 hour. The cells were then rinsed three times in PBS and
treated with the corresponding secondary antibodies:
anti-mouse antibodies conjugated with FITC or TRITC
(Sigma) and/or anti-rabbit antibody conjugated with
TRITC (Sigma).
After the labeling procedure was completed, the cells were
mounted onto glass slides using Vectashield mounting
medium with DAPI (Vector Laboratories, Burlingame, CA,
USA). The cells were then observed in a Leitz Laborlux epi-
fluorescence microscope and fluorescence micrographs
were recorded with either a Wild Leitz camera or a CCD
SB-8 camera. The images were stored using Camera 1.1
software (Dept. of Biology, Masaryk University, Brno,
Czech Republic). For the detailed studies of cytoskeleton
morphology, we used an Olympus FluoView-500 confo-
cal imaging system in combination with an inverted
Olympus IX-81 microscope. Images were recorded using
an Olympus DP70 CCD camera. The images were ana-
lyzed using analySIS FIVE software (Soft Imaging System
Nestin expression in primary cultures of glioblastoma cells Figure 1
Nestin expression in primary cultures of glioblast-
oma cells. Nestin-positive intermediate filaments were 
detected in primary cultures in cells with different morphol-
ogy – both in giant cells (A) and in smaller cells forming colo-
nies (B). Due to heterogeneity of primary culture, non-tumor 
cells exhibiting no or very poor signals for nestin were also 
detectable together with nestin-positive cells (C). Nestin-
positive filaments (A–C, green) stained by indirect immun-
ofluorescence using FITC-labeled secondary antibody; nuclei 
labeled by DAPI (A–C, blue) are shown; bar, 25 µm.BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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Localization of nestin-positive intermediate filaments in glioblastoma cells Figure 2
Localization of nestin-positive intermediate filaments in glioblastoma cells. A typical pattern of nestin-positive 
cytoskeleton in GM7 cells (A–D): the area with dense meshwork of nestin-positive filaments is located near the cell nucleus. 
Nestin-positive filaments (A–D, green) stained by indirect immunofluorescence using FITC-labeled secondary antibody; nuclei 
labeled by DAPI (A–D, blue) are shown; bar, 10 µm.BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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GmbH, Muenster, Germany) and the Olympus FluoView
Confocal Laser Scanning Microscope System 4.3.
Transmission electron microscopy
For immunodetection of nestin in ultrathin sections, cells
were rinsed in PBS and then fixed with 2% para-formalde-
hyde (Sigma) in PBS for 1 hour at room temperature. After
washing in PBS and dehydration, the cells were embedded
in LR White (Polysciences Inc., London, UK). Ultrathin
sections were labeled on grids and nestin was detected
using mouse monoclonal anti-nestin antibody (Chemi-
con) and anti-mouse gold particle conjugated secondary
antibody (Sigma). After immunolabeling, the specimens
were contrasted with 2.5% uranyl acetate (Lachema-Pliva,
Brno, Czech Republic) for 20 minutes and with Reynolds'
solution for 8 minutes at room temperature. The speci-
mens were examined using a Morgagni 268(D) transmis-
sion electron microscope (FEI Company, Hillsboro, OR,
USA). Images were recorded using a MegaView III CCD
camera (Soft Imaging System) and analyzed using Analy-
SIS software (Soft Imaging System).
Results
Characterization of cell lines
The tumor character of the derived cell lines was verified
by GTG-banding during short-term cultivation – between
passages 2 and 4. The GM7 cell line was identified as
being near-tetraploid with a large number of structural
and numerical abnormalities. The GM10 cell line was
described as being near-diploid. The number of chromo-
somes varied from 43 to 46 and chromosomes 3, 15, 19,
22 and Y were the ones most frequently found to be miss-
ing. Genetic changes in both cell lines were also con-
firmed using FISH and HR-CGH methods (data not
shown).
The astrocytic origin of these cell lines was confirmed by
indirect immunofluorescence: both vimentin- and GFAP-
positive cells were observed. However, the pattern of the
cytoskeleton was quite different. While vimentin interme-
diate filaments, displaying a typical morphology, were
detected in a majority of the cells in the culture, only a
small proportion of the cells exhibited GFAP-positive fila-
mentous structures. Most of cells in the culture showed
only a diffuse, and usually weak, fluorescent signal for
GFAP.
Arrangement of nestin filaments and microtubules in the same cell Figure 3
Arrangement of nestin filaments and microtubules in the same cell. Double labeling for both nestin (A) and tubulin 
(B) in the same cell of GM10 cell line showed no co-localization of nestin filaments with microtubules and confirmed different 
morphology of these cytoskeletal structures. Nestin-positive filaments (A, green) stained by indirect immunofluorescence using 
FITC-labeled secondary antibody; microtubules (B, red) stained by the same method using TRITC-labeled secondary antibody; 
nucleus labeled by DAPI (C, blue) are shown; bar, 10 µm.BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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In primary cultures, a different positivity for nestin was
detected in the same cell population due to the mixture of
various cell types (normal and transformed cells of astro-
cytic origin, endothelial cells) in the same culture. Trans-
formed astrocytes were usually larger in size when
compared to normal cells and, in addition to nestin posi-
tivity, abnormalities in nucleus morphology were also
detected in these cells (Fig. 1A). Nestin expression and
nestin-positive intermediate filament formation were also
observed in the smaller cells forming monolayer (Fig. 1B).
Nevertheless, nestin expression was very different in this
cell population; it varied from no signal or a diffuse signal
in the cytoplasm of, presumably, non-tumor cells up to
characteristic nestin intermediate filaments as part of the
transformed phenotype (Fig. 1C). During short-term cell
cultures (between passages 2 and 4), a decreasing number
of nestin-negative cells were observed. At passage 5, all
cells in the population showed nestin positivity.
Morphology of the nestin cytoskeleton
Cells in the monolayer expressing nestin-positive inter-
mediate filaments usually showed their nuclei in asym-
metric positions and the nestin formed a very dense
meshwork of intermediate filaments either throughout
the cytoplasm (Figure 2A) or only in a specific part of the
cell (Figure 2B–D). In both situations, we were able to
detect a region in the cytoplasm of each cell, which pro-
duced a strong signal for nestin and consisted of a dense
meshwork of nestin-positive filaments. The area of this
region was approximately the same as that of the nucleus
and it was usually located in the vicinity of the nucleus;
however, the region was not in the identical position as
the cell nucleus (Figure 2A–D).
To investigate a possible co-localization of this asymmet-
rical positioning of nestin filaments with a higher density
of cytoplasmic microtubules in the MTOC region during
interphase, a double labeling of both nestin and tubulin
was performed. The results showed no co-localization of
nestin filaments and microtubules and confirmed a differ-
ent morphology of these cytoskeletal structures during
interphase (Figure 3A–B).
In view of the nestin-positivity of the cell nuclei observed
by fluorescence microscopy (Figure 3A), we performed
software cross-sections through selected cells using confo-
cal microscopy. The results showed that nestin was not
only detectable in the cell nucleus, but also in the nucleoli
(Figure 4A,C–D).
In mitotic cells, nestin intermediate filaments were com-
pletely depolymerized and as a result, nestin was detecta-
ble as a strong diffuse fluorescence in the cytoplasm of the
cells (Figure 5A–C).
Ultrastructural distribution of nestin
Following the immunodetection of nestin in ultrathin
sections, a strong nestin positivity was observed through-
out the cytoplasm of the tumor cells (Figure 6A). The labe-
ling of nestin usually manifested as individual signals or
small clusters of particles; filamentous structures were
labeled only sporadically (Figure 7A). In keeping with the
findings of epifluorescence and confocal microscopy, nes-
tin was distinctly detectable in the cell nucleus (Figure
8A). In addition to individual particles and small clusters
of signal, several large nestin aggregates were also detected
in the nucleus (Figure 8A–C) and some very short fibers
were also noticeable within these aggregates (Figure
8B,C). A special arrangement of short spiral-like fibers was
repeatedly found in both the cytoplasm (Figure 6B) and
the cell nucleus (Figure 8D–E).
Discussion
Our study was focused on the detection and precise mor-
phological characterization of the nestin cytoskeleton in
two cell lines derived from glioblastoma multiforme. Nes-
tin was described twenty years ago [1] and it has since
been detected in many cell types, both normal and trans-
Software cross-section through a cell with nestin-positive  nucleus Figure 4
Software cross-section through a cell with nestin-
positive nucleus. Nestin occurrence in cell nuclei was con-
firmed by confocal microscopy using software cross-section 
(B–D) through the selected cell (A, the plane of software 
cross-section is highlighted by the red line). The signal for 
nestin was detected also in the cell nucleus (C). The position 
of nucleoli is indicated by arrowheads. Nestin (A, C–D, 
green) stained by indirect immunofluorescence using FITC-
labeled secondary antibody; nuclei labeled by DAPI (A–B, D, 
blue) are shown; bars, 20 µm (A), 10 µm (B–D).BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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formed and to this time most of the studies involving nes-
tin have been performed in human tissues using standard
histological techniques.
The morphological studies of the nestin cytoskeleton have
been carried out primarily in rodent cells. An identical
arrangement of cytoskeletal structures in the astrocytes of
rat hippocampus suggested a co-polymerization of nestin
and vimentin or of nestin and GFAP. Nevertheless, the
assumed co-polymerized filaments consisting of nestin
and vimentin showed a typical pattern of intermediate fil-
aments, while the co-polymerized filaments from nestin
and GFAP had a cytoplasmic microtubules-like appear-
ance [23]. Several authors have described a preferential
formation of heteropolymers with vimentin and α-intern-
exin. This is explained as being due to the very short N-ter-
minus of the nestin molecule, which is important for
protein assembly and its shortend length leads to less sta-
ble nestin homodimers [24,25]. Experiments with tar-
geted mutants confirmed heteropolymers made of nestin
and vimentin or nestin and GFAP in mouse cells [26-28].
Co-localization of nestin and vimentin or nestin and
desmin filaments, which suggests the formation of heter-
opolymers, has also been described in chinese hamster
ovary cells [29] and in the human fetal myoblast cell line
[30].
However, there has been little published information con-
cerning the morphology of intermediate filaments con-
taining re-expressed nestin in human tumor cells. Nestin
expression in human brain tumors has been detected by
immunohistochemical techniques in a number of studies
[4,11-16], and nestin positivity has been detected in the
processes of tumor cells in tissue sections [31]. If we
assume that nestin can polymerize into filaments with
only vimentin, then an identical pattern of intermediate
filaments in any given cell is to be expected. This situation
was reported in the U-373 MG glioblastoma cell line
using the same monoclonal anti-nestin antibody as was
used in our study; in these experiments, more details were
described in the intermediate filament network after nes-
tin detection [32]. Similar findings, describing the astro-
glial cells of developing rat neocortex [33], showed more
intensive staining of the co-localizing intermediate fila-
ments using monoclonal anti-nestin antibody when com-
pared to anti-vimentin and anti-GFAP antibodies.
In contrast, an incomplete co-localization of nestin with
intermediate filament bundles containing other interme-
diate filament proteins (vimentin, GFAP, neurofilament)
has been detected in the cell lines derived from PNETs and
malignant gliomas [34]. Likewise, in our cell lines, nestin
was detected as a distinct network of intermediate fila-
ments, whereas vimentin and especially GFAP showed a
Nestin in the mitotic cell Figure 5
Nestin in the mitotic cell. Nestin-positive intermediate filaments were completely depolymerized and nestin was detectable 
as a strong diffuse fluorescent signal in the cytoplasm (A–B) of GM10 cell in late anaphase (B–C). Nestin (A–B, green) stained 
by indirect immunofluorescence using FITC-labeled secondary antibody; nuclei and chromosomes labeled by DAPI (B–C, blue) 
are shown; bar, 10 µm.BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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predominantly diffuse positivity in the cytoplasm. Only
vimentin was also detected as a filamentous structure, but
this network did not completely co-localize with nestin-
positive filaments and it was primarily found surrounding
cell nucleus. When the same anti-nestin antibody was
used, the pattern of intermediate filament positivity was
independent of the anti-vimentin antibodies (all mouse
monoclonal, but different clones) or the anti-GFAP anti-
bodies (both mouse monoclonal and rabbit polyclonal)
that were used for immunostaining. A reduced GFAP-pos-
itivity in high-grade astrocytomas has been reported in
several studies [35-37] and experiments carried out on the
U-373 MG glioblastoma cell line has confirmed a tran-
scription level regulation of both nestin re-expression and
GFAP down-regulation [22]. The possible differences in
the pattern of nestin-positive and vimentin-positive fila-
ments may be caused by differences in the antibodies that
were used for nestin detection. Co-localization of nestin-
positive and vimentin-positive filaments was most often
reported when rabbit polyclonal antibody was used for
nestin detection [26,27,38], whereas, when the mouse
monoclonal antibody was used for nestin detection this,
usually, produced a more detailed and distinct nestin
cytoskeleton pattern [33,37]. In any event, the specifity of
the anti-nestin antibody used for detection has to be taken
into account [39].
The typical pattern of nestin filament organization, i.e. the
asymmetric position of the nestin-positive region in the
cytoplasm near the nucleus, which we observed, has also
been detected in U-373 and U-251 human glioma cell
lines [32,39]. In another study, the nestin cytoskeleton
was described as "button-like" clusters in the cytoplasm of
anaplastic oligoastrocytoma cells; unfortunately, it is
impossible to compare these findings with our results
Labeling of nestin in the glioblastoma cells Figure 6
Labeling of nestin in the glioblastoma cells. Strong positivity for nestin was detected in the cytoplasm of GM7 cells (A). A 
special arrangement into short spiral-like fibers in cytoplasm (B) was found repeatedly in different cells. Nestin was detected 
using immunogold labeling (A–B); bars, 1 µm (A), 0.1 µm (B).BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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because of the lower magnifications employed compared
to the magnifications used in our study [31].
The complete disassembly of the nestin network in
mitotic cells, as reported in our experiments, corresponds
with the hypothesis that nestin serves as a mediator signal
for disassembly of other intermediate filaments during
mitosis [29]. Mitotic reorganization of nestin filaments
including their partial disassembly has also been detected
in the ST15A human neuronal progenitor cell line [40].
Generally speaking, the breakdown of intermediate fila-
ments during mitosis seems to be a common feature of
nestin-positive cells [29]. The structural reorganization of
the nestin cytoskeleton during the cell cycle is mediated
by cdc2 kinase via phosphorylation [40]. Other experi-
ments have confirmed the regulation of nestin organiza-
tion by phosphorylation on Thr316 and Thr1495 sites that
are specific for cdk5 kinase [38]. In general, low levels of
nestin phosphorylation are associated with its assembly
into filamentous structures [25].
Without question, the most important finding of our
study is the discovery of nestin in the cell nucleus, which
was unequivocally demonstrated both by fluorescence
microscopy and transmission electron microscopy. Even
using indirect immunofluorescence, a diffuse signal for
nestin in the position of cell nucleus has also been identi-
fied in primary cultures of glioblastoma cells [36].
Another study has demonstrated the presence of nestin in
the nucleus of neuroblastoma cells by means of cell frac-
tionation and immunoblotting, and other experiments
have showed that nestin binds to nuclear DNA in cell lines
Ultrastructural distribution of nestin in the cytoplasm of glioblastoma cells Figure 7
Ultrastructural distribution of nestin in the cytoplasm of glioblastoma cells. Labeling of nestin appeared usually as 
individual signals or small clusters of particles; filamentous structures (arrowheads) were labeled only sporadically in the cyto-
plasm of GM7 cells (A). Nestin was detected using immunogold labeling; bar, 1 µm (A). Negative control stained with second-
ary antibody only: cytoplasm; bar, 0.5 µm (B).BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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Detection of nestin in the cell nucleus Figure 8
Detection of nestin in the cell nucleus. Labeled nestin was distinctly detectable also in the cell nucleus as individual parti-
cles and small clusters of signal (A); several larger nestin aggregates (B–C) were also observed. Arrows indicate very short fib-
ers in these aggregates (B–C). A special arrangement into short spiral-like fibers in cell nucleus (D–E) was found repeatedly in 
different cells. Nestin was detected using immunogold labeling; bars, 1 µm (A), 0.1 µm (B–E). Negative control stained with 
secondary antibody only: nucleus and nucleolus (Nu); bar, 0.5 µm (F).BMC Cancer 2006, 6:32 http://www.biomedcentral.com/1471-2407/6/32
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with N-myc amplification [41]. Collectively, all these find-
ings suggest that nestin expression in tumor cells is closely
related to their dedifferentiated status and increased
malignancy. In addition to the role of the cytoskeletal
components in cell growth and motility, which is associ-
ated with metastatic potential, some proteins of the inter-
mediate filaments identified in the cell nucleus may affect
organization of chromatin or they may serve as specific
regulators of gene expression [41,42].
Conclusion
Using indirect immunofluorescence, we described the re-
expression of nestin and the specific morphology of nes-
tin-positive intermediate filaments in glioblastoma cells.
Again, the most significant finding is the evidence of nes-
tin in the cell nucleus, which we detected using transmis-
sion electron microscopy and immunogold labelling.
Although other studies have suggested that changes in the
intermediate filament proteins in brain tumors are associ-
ated with tumor malignancy and invasiveness, the role of
nestin molecules in the nucleus of tumor cells still
remains unclear. A thourough study of nestin in the
nucleus of tumor cells on the ultrastructural level in com-
bination with a precise molecular cytogenetic characteri-
zation of these cell lines will be a main aim of our future
research.
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